Trial intelligence / Profile preview

Durolane in TMJ Arthroscopy

NCT04110587Phase 4Completed

Sponsor
Complutense University of Madrid
Start
Dec 2013
Primary completion
Jul 2019
Modality
Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of hyaluronic acid in temporomandibular joint disorders (TMD), sponsored by Complutense University of Madrid. Started Dec 2013; status: completed.

02

Drugs

hyaluronic acid
03

Conditions

temporomandibular joint disorders (TMD)

Beyond the preview

Go deeper on NCT04110587.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04110587.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call